NasdaqGS - Nasdaq Real Time Price • USD
Genmab A/S (GMAB)
At close: May 31 at 4:00 PM EDT
Pre-Market: 8:33 AM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
35,289,000.00
30,119,000.00
24,627,000.00
21,143,000.00
--
Total Liabilities Net Minority Interest
3,679,000.00
2,837,000.00
2,431,000.00
2,022,000.00
--
Total Equity Gross Minority Interest
31,610,000.00
27,282,000.00
22,196,000.00
19,121,000.00
--
Total Capitalization
31,610,000.00
27,282,000.00
22,196,000.00
19,121,000.00
--
Common Stock Equity
31,610,000.00
27,282,000.00
22,196,000.00
19,121,000.00
--
Capital Lease Obligations
770,000.00
597,000.00
425,000.00
319,000.00
--
Net Tangible Assets
31,509,000.00
27,136,000.00
21,942,000.00
18,783,000.00
--
Working Capital
30,655,000.00
26,395,000.00
21,168,000.00
17,538,000.00
--
Invested Capital
31,610,000.00
27,282,000.00
22,196,000.00
19,121,000.00
--
Tangible Book Value
31,509,000.00
27,136,000.00
21,942,000.00
18,783,000.00
--
Total Debt
770,000.00
597,000.00
425,000.00
319,000.00
--
Share Issued
66,074.54
65,961.57
66,006.78
65,545.75
--
Ordinary Shares Number
65,330.37
65,371.63
65,718.46
65,413.64
--
Treasury Shares Number
744.17
589.95
288.33
132.11
--
12/31/2019 - 6/1/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALNY Alnylam Pharmaceuticals, Inc.
148.43
-1.07%
ARGX argenx SE
371.02
+2.45%
LEGN Legend Biotech Corporation
40.01
-7.66%
CGEM Cullinan Therapeutics, Inc.
23.50
+3.12%
HALO Halozyme Therapeutics, Inc.
44.29
+2.17%
BGNE BeiGene, Ltd.
148.85
-3.50%
INCY Incyte Corporation
57.79
+0.86%
RPRX Royalty Pharma plc
27.41
+3.87%
ASND Ascendis Pharma A/S
135.10
-1.71%
ZEAL.CO Zealand Pharma A/S
638.00
-0.23%